QA Audit Procedure [GxP / QC / QA]

posted by swapnil.kuche – 2011-01-20 07:47 (5628 d 00:39 ago) – Posting: # 6452
Views: 30,394

(edited on 2011-01-20 11:20)

Dear All,

Most of Quality Assurance departments used to claim that 20% raw data (Inprocess & Retrospective) and final bioequivalence report will be audited during course of conduct of the study.
My question is
  1. Do you feel it's ideal procedure to be followed?
  2. If yes. Do you have any reference regulatory guidance or any literature for the same supporting above mentioned statement?
    :ponder:
Thanks
Swapnil

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
155 visitors (0 registered, 155 guests [including 14 identified bots]).
Forum time: 09:26 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5